beta

CHMA

Chiasma, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Chiasma, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing and commercializing oral forms of therapies that are available by injection. Its products include octreotide capsules and clinical trials. The firm's Transient Permeability Enhancer (TPE) technology platform, seeks to develop oral medications. The company was founded by Shmuel A. Ben-Sasson and Guy Yachin in 2001 and is headquartered in Waltham, MA.

Market Cap: 264 Million

Primary Exchange: NASDAQ

Website: http://www.chiasmapharma.com

Shares Outstanding: 42.3 Million

Float: 31.1 Million

Dividend: (%)

Beta: 1.03693691537804

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 2772 trading days

From: 2015-09-09 To: 2020-05-29

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud